To sum up, morphological and biochemical analysis show an increase in diffuse pTau in EOFAD and AOFAD patients, pointing to differences in Tau phosphorylation patterns and possible impact in synaptic loss. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.